{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:12:12Z","timestamp":1778886732158,"version":"3.51.4"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Apolipoprotein (apo) E4, being a major genetic risk factor for Alzheimer\u2019s disease (AD), is actively involved in the proteolytic processing of amyloid precursor protein (APP) to amyloid \u03b2 (A\u03b2) peptide, the principle constituent of amyloid plaques in Alzheimer Disease (AD) patients. ApoE4 is believed to affect APP processing through intracellular cholesterol homeostasis, whereas lowering the cholesterol level by pharmacological agents has been suggested to reduce A\u03b2 production. This study has investigated the effects of hypolipidemic agents fenofibrate, and the flavonoids\u2013naringenin and diosmetin\u2013on apoE4-induced APP processing in rat neuroblastoma cells stably transfected with human wild-type APP 695 (B103-hAPP695wt).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>B103-hAPP695wt cells were pretreated with different doses of flavonoids and fenofibrate for 1 h prior to apoE4 exposure for 24 h. ApoE4-induced production of intra- and extracellular A\u03b2 peptides has been reduced with fenofibrate, naringenin, and diosmetin treatments. Pretreatment with diosmetin has significantly reduced apoE4-induced full-length APP (fl- APP) expression, whereas naringenin and fenofibrate had no effect on it. In addition, the increase in the apoE4-induced secretion of sAPPtotal and sAPP\u03b1 has been dose-dependently reduced with drug pretreatment. On the other hand, the decrease in the expression of both APP-carboxy terminal fragments (CTF)-\u03b1 and \u2013\u03b2 (generated by the \u03b1- or \u03b2-secretase cleavage of APP) by apoE4 was dose-dependently increased in cells pretreated with fenofibrate and naringenin but not diosmetin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Thus, we suggest that fenofibrate, naringenin, and diosmetin treatments can reduce apoE4- induced A\u03b2 production by distinct mechanisms that may prove useful in developing drugs for AD patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2023.1245895","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T04:14:18Z","timestamp":1703218458000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Flavonoids and fibrate modulate apoE4-induced processing of amyloid precursor protein in neuroblastoma cells"],"prefix":"10.3389","volume":"17","author":[{"given":"Viralkumar","family":"Davra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenza E.","family":"Benzeroual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1471-4159.2009.06355.x","article-title":"Selective modulation of amyloid-beta peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Abeta levels","volume":"111","author":"Abdul-Hay","year":"2009","journal-title":"J. Neurochem."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1046\/j.1471-4159.1996.67020699.x","article-title":"In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3\u03b2","volume":"67","author":"Aplin","year":"1996","journal-title":"J. Neurochem."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"109793","DOI":"10.1016\/j.pnpbp.2019.109793","article-title":"Neuroprotective effect of PPAR alpha and gamma agonists in a mouse model of amyloidogenesis through modulation of the Wnt\/beta catenin pathway via targeting alpha- and beta-secretases","volume":"97","author":"Assaf","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.1007\/s11033-021-06512-9","article-title":"Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease","volume":"48","author":"Athar","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/plants9030288","article-title":"Citrus flavones: an update on sources, biological functions, and health promoting properties","volume":"9","author":"Barreca","year":"2020","journal-title":"Plants (Basel, Switzerland)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"9428","DOI":"10.1021\/bi800993c","article-title":"Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): does APP function as a cholesterol sensor?","volume":"47","author":"Beel","year":"2008","journal-title":"Biochemistry"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1046\/j.1471-4159.2002.00985.x","article-title":"Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity","volume":"82","author":"Beher","year":"2002","journal-title":"J. Neurochem."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"10405","DOI":"10.1523\/JNEUROSCI.2288-09.2009","article-title":"Gamma-secretase inhibition reduces spine density in vivo via an amyloid precursor protein-dependent pathway","volume":"29","author":"Bittner","year":"2009","journal-title":"J. Neurosci."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1006\/nbdi.1999.0251","article-title":"Apolipoprotein E expression by neurons surviving excitotoxic stress","volume":"6","author":"Boschert","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.bbalip.2010.03.004","article-title":"Intracellular cholesterol homeostasis and amyloid precursor protein processing","volume":"1801","author":"Burns","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tips.2003.12.004","article-title":"Beta-secretase inhibition for the treatment of Alzheimer's disease--promise and challenge","volume":"25","author":"Citron","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"6743","DOI":"10.1523\/JNEUROSCI.1381-10.2010","article-title":"Acute \u03b3 -secretase inhibition of nonhuman primate CNS shifts amyloid precursor protein (APP) metabolism from amyloid-\u03b2 production to alternative APP fragments without amyloid-\u03b2\u2002rebound","volume":"30","author":"Cook","year":"2010","journal-title":"J. Neurosci."},{"key":"ref002","doi-asserted-by":"publisher","first-page":"8445","DOI":"10.1073\/pnas.1504890112","article-title":"Activation of peroxisome proliferator-activated receptor \u03b1 stimulates ADAM10-mediated proteolysis of APP","volume":"112","author":"Corbett","year":"2015","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science (New York, N.Y.)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S1474-4422(16)00127-7","article-title":"Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond","volume":"15","author":"Cuyvers","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref16","first-page":"1309","article-title":"Apolipoprotein E-epsilon 4 allele and Alzheimer's disease","volume":"342","author":"Czech","year":"1993","journal-title":"Lancet (London, England)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1042\/BCJ20180068","article-title":"ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and A\u03b2 production independently of their cholesterol efflux capacity","volume":"475","author":"Dafnis","year":"2018","journal-title":"Biochem. J."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1523\/JNEUROSCI.22-09-03445.2002","article-title":"Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice","volume":"22","author":"Dewachter","year":"2002","journal-title":"J. Neurosci."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"588516","DOI":"10.3389\/fneur.2020.588516","article-title":"The protective effects of peroxisome proliferator-activated receptor gamma in cerebral ischemia-reperfusion injury","volume":"11","author":"Ding","year":"2020","journal-title":"Front. Neurol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/j.1460-2075.1988.tb02900.x","article-title":"Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease","volume":"7","author":"Dyrks","year":"1988","journal-title":"EMBO J."},{"key":"ref001","doi-asserted-by":"publisher","first-page":"104724","DOI":"10.1016\/j.nbd.2019.104724","article-title":"APOE in the normal brain","volume":"136","author":"Flowers","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1124\/mol.107.034009","article-title":"Cholesterol-like effects of selective cyclooxygenase inhibitors and fibrates on cellular membranes and amyloid-beta production","volume":"72","author":"Gamerdinger","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1073\/pnas.85.16.6218","article-title":"Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Ca2+\/calmodulin-dependent protein kinase II","volume":"85","author":"Gandy","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"100179","DOI":"10.1016\/j.phyplu.2021.100179","article-title":"Comprehensive review on therapeutic and phytochemical exploration of diosmetin: a promising moiety","volume":"2","author":"Garg","year":"2022","journal-title":"Phytomed. Plus"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1359-6446(01)01965-1","article-title":"Cholesterol modulation as an emerging strategy for the treatment of Alzheimer's disease","volume":"6","author":"Golde","year":"2001","journal-title":"Drug Discov. Today"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1016\/j.chroma.2011.07.073","article-title":"From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry","volume":"1218","author":"Grimm","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jnutbio.2011.06.015","article-title":"Trans fatty acids enhance amyloidogenic processing of the Alzheimer amyloid precursor protein (APP)","volume":"23","author":"Grimm","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.emboj.7600061","article-title":"Take five--BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation","volume":"23","author":"Haass","year":"2004","journal-title":"EMBO J."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1016\/S0021-9258(18)53650-4","article-title":"beta-amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms","volume":"268","author":"Haass","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"Haass","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/359322a0","article-title":"Amyloid beta-peptide is produced by cultured cells during normal metabolism","volume":"359","author":"Haass","year":"1992","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"16576","DOI":"10.1074\/jbc.273.26.16576","article-title":"Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol","volume":"273","author":"Howland","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","article-title":"ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and A\u03b2 secretion","volume":"168","author":"Huang","year":"2017","journal-title":"Cells"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1042\/NS20180203","article-title":"The role of APOE4 in Alzheimer's disease: strategies for future therapeutic interventions","volume":"3","author":"Hunsberger","year":"2019","journal-title":"Neuronal Signal."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000113705","article-title":"ACAT as a drug target for Alzheimer's disease","volume":"5","author":"Huttunen","year":"2008","journal-title":"Neurodegener Dis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1096\/fj.09-134999","article-title":"Inhibition of acyl-coenzyme a: cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathway","volume":"23","author":"Huttunen","year":"2009","journal-title":"FASEB J."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1006\/bbrc.1999.0637","article-title":"Phosphorylation of the cytoplasmic domain of Alzheimer\u2019s beta-amyloid precursor protein at Ser655 by a novel protein kinase","volume":"258","author":"Isohara","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","article-title":"Visualization of a beta 42(43) and a beta 40 in senile plaques with end-specific a beta monoclonals: evidence that an initially deposited species is a beta 42(43)","volume":"13","author":"Iwatsubo","year":"1994","journal-title":"Neuron"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.trsl.2006.08.001","article-title":"Hypocholesterolemic and antioxidative effects of naringenin and its two metabolites in high-cholesterol fed rats","volume":"149","author":"Jeon","year":"2007","journal-title":"Transl. Res."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1371\/annotation\/a0bb886d-d345-4a20-a82e-adce9b047798","article-title":"Correction: genetic evidence implicates the immune system and cholesterol metabolism in the Aetiology of Alzheimer's disease","volume":"6","author":"Jones","year":"2011","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer's disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.1073\/pnas.081612998","article-title":"Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10","volume":"98","author":"Kojro","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.1021\/jm900188z","article-title":"Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease","volume":"52","author":"Kreft","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nm1235","article-title":"Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production","volume":"11","author":"Kukar","year":"2005","journal-title":"Nat. Med."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.3390\/nu14112248","article-title":"Diosmetin targeted at peroxisome proliferator-activated receptor gamma alleviates advanced glycation end products induced neuronal injury","volume":"14","author":"Lai","year":"2022","journal-title":"Nutrients"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.molmed.2010.07.008","article-title":"APOE and cholesterol homeostasis in Alzheimer's disease","volume":"16","author":"Leduc","year":"2010","journal-title":"Trends Mol. Med."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1006\/bbrc.2001.5001","article-title":"Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits","volume":"284","author":"Lee","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1083\/jcb.200301115","article-title":"APP processing is regulated by cytoplasmic phosphorylation","volume":"163","author":"Lee","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"e13261","DOI":"10.1111\/jfbc.13261","article-title":"Inhibitory effect of diosmetin on inflammation and lipolysis in coculture of adipocytes and macrophages","volume":"44","author":"Lee","year":"2020","journal-title":"J. Food Biochem."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/WNL.0b013e318217e7a4","article-title":"Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease","volume":"76","author":"Li","year":"2011","journal-title":"Neurology"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","article-title":"Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism","volume":"36","author":"Mahley","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.ijbiomac.2018.06.190","article-title":"In vitro neuroprotective effects of naringenin nanoemulsion against \u03b2-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation","volume":"118","author":"Md","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1523\/JNEUROSCI.4264-11.2012","article-title":"Differential effects between \u03b3-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice","volume":"32","author":"Mitani","year":"2012","journal-title":"J. Neurosci."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/bs.irn.2015.05.008","article-title":"Lipidomics of human brain aging and Alzheimer's disease pathology","volume":"122","author":"Naud\u00ed","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1021\/jm101168r","article-title":"\u03b3-Secretase modulators as potential disease modifying anti-Alzheimer's drugs","volume":"54","author":"Oehlrich","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1042\/BJ20100321","article-title":"Ectodomain shedding of the notch ligand Jagged1 is mediated by ADAM17, but is not a lipid-raft-associated event","volume":"432","author":"Parr-Sturgess","year":"2010","journal-title":"Biochem. J."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.neurobiolaging.2009.06.002","article-title":"A novel pathway for amyloid precursor protein processing","volume":"32","author":"Portelius","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/ncb1001-905","article-title":"Acyl-coenzyme a: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide","volume":"3","author":"Puglielli","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1006\/jmbi.2001.4535","article-title":"Phosphorylation-induced structural changes in the amyloid precursor protein cytoplasmic tail detected by NMR","volume":"307","author":"Ramelot","year":"2001","journal-title":"J. Mol. Biol."},{"key":"ref66","first-page":"3504","article-title":"Is apolipoprotein E4 an important risk factor for vascular dementia?","volume":"7","author":"Rohn","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/cells9051215","article-title":"Alzheimer's disease, a lipid story: involvement of peroxisome proliferator-activated receptor \u03b1","volume":"9","author":"S\u00e1ez-Orellana","year":"2020","journal-title":"Cells"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jneuroim.2016.08.018","article-title":"Diosmin reduces cerebral A\u03b2 levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice","volume":"299","author":"Sawmiller","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","article-title":"The multiplex model of the genetics of Alzheimer's disease","volume":"23","author":"Sims","year":"2020","journal-title":"Nat. Neurosci."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"105027","DOI":"10.1016\/j.jff.2022.105027","article-title":"Preparation and pharmacokinetic study of diosmetin long-circulating liposomes modified with lactoferrin","volume":"91","author":"Sun","year":"2022","journal-title":"J. Funct. Foods"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41467-022-28280-1","article-title":"Inferring protein expression changes from mRNA in Alzheimer's dementia using deep neural networks","volume":"13","author":"Tasaki","year":"2022","journal-title":"Nat. Commun."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/jnr.22640","article-title":"Intraneuronal amyloid \u03b2 oligomers cause cell death via endoplasmic reticulum stress, endosomal\/lysosomal leakage, and mitochondrial dysfunction in vivo","volume":"89","author":"Umeda","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science (New York, N.Y.)"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"44945","DOI":"10.1074\/jbc.M407986200","article-title":"Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes","volume":"279","author":"Vetrivel","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1471-4159.2011.07477.x","article-title":"Identification and biology of \u03b1-secretase","volume":"120","author":"Vingtdeux","year":"2012","journal-title":"J. Neurochem."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cmet.2013.03.016","article-title":"Metabolic stress modulates Alzheimer's \u03b2-secretase gene transcription via SIRT1-PPAR\u03b3-PGC-1 in neurons","volume":"17","author":"Wang","year":"2013","journal-title":"Cell Metab."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fnmol.2017.00294","article-title":"Modifications and trafficking of APP in the pathogenesis of Alzheimer's disease","volume":"10","author":"Wang","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"27618","DOI":"10.1038\/srep27618","article-title":"Localization of PPAR isotypes in the adult mouse and human brain","volume":"6","author":"Warden","year":"2016","journal-title":"Sci. Rep."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s11064-020-02993-5","article-title":"The novel role of PPAR alpha in the brain: promising target in therapy of Alzheimer's disease and other neurodegenerative disorders","volume":"45","author":"W\u00f3jtowicz","year":"2020","journal-title":"Neurochem. Res."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1749-6632.1996.tb34440.x","article-title":"Differential regulation of APP secretion by apolipoprotein E3 and E4","volume":"777","author":"Wolozin","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.nbd.2007.10.005","article-title":"Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production","volume":"29","author":"Xiong","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"18700","DOI":"10.1073\/pnas.0508693102","article-title":"Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target","volume":"102","author":"Ye","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-neuro-071013-014300","article-title":"Apolipoprotein E in Alzheimer's disease: an update","volume":"37","author":"Yu","year":"2014","journal-title":"Annu. Rev. Neurosci."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijdevneu.2014.10.004","article-title":"Fenofibrate reduces amyloidogenic processing of APP in APP\/PS1 transgenic mice via PPAR-\u03b1\/PI3-K pathway","volume":"38","author":"Zhang","year":"2014","journal-title":"Int. J. Dev. Neurosci."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11010-015-2480-5","article-title":"PPAR-\u03b1 agonist regulates amyloid-\u03b2 generation via inhibiting BACE-1 activity in human neuroblastoma SH-SY5Y cells transfected with APPswe gene","volume":"408","author":"Zhang","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1756-6606-4-3","article-title":"APP processing in Alzheimer's disease","volume":"4","author":"Zhang","year":"2011","journal-title":"Mol. Brain"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10571-017-0519-8","article-title":"Protective Role Of Naringenin Against A\u03b225-35-Caused Damage via ER and PI3K\/Akt-Mediated Pathways","volume":"38","author":"Zhang","year":"2018","journal-title":"Cell. Mol. Neurobiol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1245895\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T04:14:22Z","timestamp":1703218462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1245895\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,22]]},"references-count":89,"alternative-id":["10.3389\/fnins.2023.1245895"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1245895","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,22]]},"article-number":"1245895"}}